BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1856 related articles for article (PubMed ID: 31950990)

  • 1. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
    Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
    Cao D; Wang Y; Li D; Wang L
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
    Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y
    J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
    Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H
    Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma.
    Xu Y; Lin G; Liu Y; Lin X; Lin H; Guo Z; Xu Y; Lin Q; Chen S; Yang J; Zeng Y
    BMC Cancer; 2022 Feb; 22(1):188. PubMed ID: 35183135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma.
    Wu X; Sui Z; Zhang H; Wang Y; Yu Z
    Front Oncol; 2020; 10():554759. PubMed ID: 33042838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.
    Hou J; Yao C
    Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.
    Chen L; Ren Z; Cai Y
    Biomed Res Int; 2021; 2021():4093426. PubMed ID: 33628780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 93.